Fibrosis  >>  Isentress (raltegravir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Isentress (raltegravir) / Merck (MSD)
LIVERAL, NCT01289951: Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Completed
1
10
Europe
Raltegravir 400 mg/12hours
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal, Merck Sharp & Dohme LLC
Human Immunodeficiency Virus, Hepatitis C
06/11
10/11

Download Options